Merrimack Pharmaceuticals Probability of Future Stock Price Finishing Over 11.8

MACKDelisted Stock  USD 11.96  0.12  1.01%   
Merrimack Pharmaceuticals' future price is the expected price of Merrimack Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Merrimack Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
  
Please specify Merrimack Pharmaceuticals' target price for which you would like Merrimack Pharmaceuticals odds to be computed.

Merrimack Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Merrimack Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Merrimack Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Merrimack Pharmaceuticals is not yet fully synchronised with the market data
Merrimack Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (1.18 M) with loss before overhead, payroll, taxes, and interest of (9.1 M).
Merrimack Pharmaceuticals currently holds about 13.36 M in cash with (1.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.0.
Roughly 63.0% of the company shares are owned by institutional investors

Merrimack Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Merrimack Stock often depends not only on the future outlook of the current and potential Merrimack Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Merrimack Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding14.3 M
Cash And Short Term Investments18.9 M

Merrimack Pharmaceuticals Technical Analysis

Merrimack Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Merrimack Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Merrimack Pharmaceuticals. In general, you should focus on analyzing Merrimack Stock price patterns and their correlations with different microeconomic environments and drivers.

Merrimack Pharmaceuticals Predictive Forecast Models

Merrimack Pharmaceuticals' time-series forecasting models is one of many Merrimack Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Merrimack Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Merrimack Pharmaceuticals

Checking the ongoing alerts about Merrimack Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Merrimack Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Merrimack Pharmaceuticals is not yet fully synchronised with the market data
Merrimack Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (1.18 M) with loss before overhead, payroll, taxes, and interest of (9.1 M).
Merrimack Pharmaceuticals currently holds about 13.36 M in cash with (1.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.0.
Roughly 63.0% of the company shares are owned by institutional investors
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Consideration for investing in Merrimack Stock

If you are still planning to invest in Merrimack Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Merrimack Pharmaceuticals' history and understand the potential risks before investing.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios